Your Followed Topics

business6h ago

Intellia Therapeutics, Inc. Q1 2026: Revenue $15M, EPS $(0.81) — 10-Q Summary

https://www.tradingview.com/news/tradingview:e204c56a41797:0-intellia-therapeutics-inc-q1-2026-revenue-15m-eps-0-81-10-q-summary/https://variety.com/2026/tv/news/fox-corp-q3-profit-dip-super-bowl-1236744538/https://seekingalpha.com/article/4902486-fox-corporation-foxa-q3-2026-earnings-call-transcript
Tradingview.com and 3 more
Intellia Therapeutics, Inc. Q1 2026: Revenue $15M, EPS $(0.81) — 10-Q Summary Open in Tradingview.com
Highlights
  • Target Hospitality sees 1Q2026 revenue rise to $72.8M, up 4% YoY as WHS expansion boosts the portfolio.
  • Net loss attributable to common stockholders widens to $(12.9)M in Q1 2026, with diluted EPS at $(0.13) amid ongoing profitability pressures.
  • WHS expansion and higher specialty rental income drive 4% revenue growth, signaling a shift in mix and longer-term demand.
Vote 50
0

References

Fox Corp. Sees Q3 Profit Dip, Citing Absence of Super Bowl

Fox Corp. Sees Q3 Profit Dip, Citing Absence of Super Bowl

Fox Corporation (FOXA) Q3 2026 Earnings Call Transcript

Fox Corporation (FOXA) Q3 2026 Earnings Call Transcript

Fox March Quarter Revenue Dips With No Super Bowl As Company Gears Up For World Cup

Fox March Quarter Revenue Dips With No Super Bowl As Company Gears Up For World Cup

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 785 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement